Denali Therapeutics Inc. DNLI
18.45 USD +0.25 (+1.37%)
Regular-session close
18.45 0.00 0.00%
After hours · Nov 20, 4:52 PM ET
17.92 Day range 18.85
16.02 52-week range 27.21
- YTD
- +11.75%
- 1 year
- +7.52%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -555.34M | -487.34M | -196.70M | -340.74M | -295.75M | |
| -512.54M | -422.77M | -145.22M | -325.99M | -290.58M | |
| -2.97 | -2.57 | -1.06 | -2.60 | -2.39 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 205.33M | 174.96M | 127.11M | 218.04M | 293.48M | |
| 1.14B | 1.37B | 1.15B | 1.46B | 1.40B | |
| 131.09M | 144.50M | 122.96M | 417.81M | 441.87M | |
| 32.74M | 42.29M | 44.98M | 53.03M | 58.55M | |
| 1.01B | 1.23B | 1.03B | 1.04B | 962.29M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -412.60M | -347.69M | -357.99M | -244.72M | -211.39M | |
| 255.28M | -88.76M | 249.31M | -141.39M | -21.63M | |
| 189.22M | 484.30M | 17.82M | 310.67M | 19.35M | |
| -9.50M | -15.91M | -12.94M | -17.83M | -8.50M | |
| 31.90M | 47.85M | -90.86M | -75.43M | -213.67M |
